Filing Details

Accession Number:
0001209784-17-000048
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-02 19:59:33
Reporting Period:
2017-05-31
Filing Date:
2017-06-02
Accepted Time:
2017-06-02 19:59:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1116463 Orasure Technologies Inc OSUR Surgical & Medical Instruments & Apparatus (3841) 364370966
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1209780 H Ronald Spair 220 East First Street
Bethlehem PA 18015
Coo & Cfo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-31 10,251 $5.19 119,317 No 4 M Direct
Common Stock Acquisiton 2017-05-31 39,749 $5.71 159,066 No 4 M Direct
Common Stock Disposition 2017-05-31 50,000 $15.06 109,066 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nonqualified stock options Disposition 2017-05-31 10,251 $0.00 10,251 $5.19
Common Stock Nonqualified stock options Disposition 2017-05-31 39,749 $0.00 39,749 $5.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-01-25 No 4 M Direct
64,737 2024-02-03 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 150,063 Indirect By Nonqualified Deferred Compensation Plan
Footnotes
  1. Nonqualified stock options granted on January 25, 2010 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.
  2. Nonqualified stock options granted on February 3, 2014 vesting and exercisable over a four-year period, with one-fourth of the options vesting on the first anniversary date of the grant and the remainder vesting ratably on a monthly basis, over the remaining 36 months.